News

News

April 27, 2018
AnaptysBio To Participate in Upcoming Investor Conferences

SAN DIEGO , April 27, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that that company will participate in the following investor

Displaying 11 - 18 of 18